Cargando…

Ulcerative injection site reaction after third COVID‐19 vaccine dose with mRNA‐1273

Detalles Bibliográficos
Autores principales:	Barei, Francesca, Marletta, Dario A., Marti‐Marti, Ignasi, Maronese, Carlo A., Genovese, Giovanni, Marzano, Angelo V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348031/ https://www.ncbi.nlm.nih.gov/pubmed/35678474 http://dx.doi.org/10.1111/dth.15631

Ejemplares similares

MRNA-1273: Rhabdomyolysis and injection site pain: case report
Publicado: (2021)

Delayed Injection Site Reaction After mRNA-1273 Vaccination in Japan: A Retrospective, Cross-Sectional Study
por: Hibino, Masaya, et al.
Publicado: (2021)

mRNA-1273: Soreness at the injection site, fatigue and herpes zoster : case report
Publicado: (2021)

Dermal Amyloid Deposits: A Possible Misleading Pathologic Finding
por: Giacalone, Serena, et al.
Publicado: (2023)

Keratosis lichenoides chronica: A case report and focused overview of the literature
por: Aromolo, Italo Francesco, et al.
Publicado: (2021)

Widespread Papules in a 70-year-old Man: A Quiz
por: AROMOLO, Italo F., et al.
Publicado: (2022)

Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria
por: Genovese, Giovanni, et al.
Publicado: (2021)

Reply to “Successful treatment of nodular human immunodeficiency virus–associated Kaposi sarcoma of the foot utilizing combination intralesional bleomycin and cryotherapy.”
por: Maronese, Carlo Alberto, et al.
Publicado: (2022)

Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination
por: Channa, Leelakrishna, et al.
Publicado: (2021)

Pustular Psoriasis: From Pathophysiology to Treatment
por: Genovese, Giovanni, et al.
Publicado: (2021)

The Intriguing Links between Psoriasis and Bullous Pemphigoid
por: Maronese, Carlo Alberto, et al.
Publicado: (2022)

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
por: Hall, Victoria G., et al.
Publicado: (2021)

Acute myocarditis after the third dose of COVID‐19 mRNA‐1273 vaccine
por: Yamada, Takayuki
Publicado: (2023)

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
por: Parés-Badell, Oleguer, et al.
Publicado: (2022)

Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients
por: Giuliano, Anna, et al.
Publicado: (2023)

Ulcerative injection-site reaction associated with dupilumab therapy
por: Phan, Michael, et al.
Publicado: (2020)

mRNA-1273/tozinameran: Delayed cutaneous reactions: 26 case reports
Publicado: (2021)

Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments
por: Maronese, Carlo Alberto, et al.
Publicado: (2022)

Binding Sites of miR-1273 Family on the mRNA of Target Genes
por: Ivashchenko, Anatoly, et al.
Publicado: (2014)

Myocarditis After the Third Dose of mRNA-1273 Coronavirus Disease 2019 (COVID-19) Vaccine
por: Kawahara, Hiroshi, et al.
Publicado: (2022)

Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis
por: Ferrucci, Silvia, et al.
Publicado: (2021)

Covid-19-vaccine/mrna-1273: (18)F-FDG avidity in the lymph nodes and injection site soreness: 2 case reports
Publicado: (2022)

Association Between Fever and Antibody Titer Trends After a Third Dose of the mRNA-1273 Vaccine
por: Matsumoto, Naomi, et al.
Publicado: (2022)

Editorial: Cutaneous immunology
por: Avallone, Gianluca, et al.
Publicado: (2023)

mRNA-1273: Myocarditis: case report
Publicado: (2021)

mrna-1273: Erythema nodosum: case report
Publicado: (2021)

mrna-1273: Immediate hypersensitivity: case report
Publicado: (2021)

mrna-1273: Acute myocarditis: case report
Publicado: (2021)

mRNA-1273: Myopericarditis: case report
Publicado: (2021)

mRNA 1273: Anaphylaxis: case report
Publicado: (2021)

mrna-1273: Haematuria: 2 case reports
Publicado: (2021)

The clinical and pathologic spectrum of mucocutaneous reactions after COVID-19 vaccinations in three tertiary referral centers of northern Italy
por: Paolino, Giovanni, et al.
Publicado: (2023)

Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan
por: Kitagawa, Hiroki, et al.
Publicado: (2022)

Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital Employees
por: Jacobson, Mark A, et al.
Publicado: (2021)

Clinical, dermoscopic and histopathological findings in localized human monkeypox: a case from northern Italy
por: Maronese, Carlo A., et al.
Publicado: (2022)

mRNA-1273: Various toxicities: case report
Publicado: (2021)

mrna-1273/tozinameran: Myocarditis: 8 case reports
Publicado: (2021)

mrna-1273: Minimal change disease: case report
Publicado: (2021)

mRNA-1273: Thyroiditis: 3 case reports
Publicado: (2021)

mrna-1273: Bullous drug eruption: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6o09fhk3akffc8h6ibppj4lt9f